Therapeutic targeting of EP300/CBP by bromodomain inhibition in acute myeloid leukemia
Authors
Nicosia, LucianoSpencer, Gary J
Brooks, N.
Amaral, Fabio
Basma, Naseer J
Chadwick, John
Revell, Bradley
Wingelhofer, Bettina
Maiques-Diaz, Alba
Ciceri, Filippo
Wiseman, Daniel H
Pegg, N. A.
West, W.
Knurowski, T.
Frese, K.
Clegg, K.
Campbell, V. L.
Copland, M.
Searle, Emma
Somervaille, Tim C P
Affiliation
Cancer Research UK Manchester Institute, The University of Manchester, ManchesterIssue Date
2022
Metadata
Show full item recordCitation
Nicosia L, Spencer GJ, Brooks N, Amaral F, Basma N, Chadwick J, et al. Therapeutic Targeting of EP300/CBP By Bromodomain Inhibition in Acute Myeloid Leukemia. Blood. 2022 Nov;140:8774-5. PubMed PMID: WOS:000893230301382.Journal
BloodDOI
10.1182/blood-2022-166260Additional Links
https://dx.doi.org/10.1182/blood-2022-166260Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1182/blood-2022-166260